4,219 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
JNJ Johnson & Johnson $139.96 $375.48B Downtrend
Article Searches
Dutch Eye Care Company Grand Vision Is Worth A Look https://seekingalpha.com/article/4213500-dutch-eye-care-company-grand-vision-worth-look?source=feed_all_articles Oct 23, 2018 - Grandvision should do well with aging population needing eye care. HAL Trust is the majority owner. The stock is reasonably priced.
Stocks making the biggest move premarket: UTX, HOG, VZ, MMM, CAT & more https://www.cnbc.com/2018/10/23/stocks-making-the-biggest-move-premarket-utx-hog-vz-mmm-cat--more.html Oct 23, 2018 - Names on the move ahead of the open.
Wall Street Breakfast: More Gloom For Equities https://seekingalpha.com/article/4213336-wall-street-breakfast-gloom-equities?source=feed_tag_wall_st_breakfast Oct 23, 2018 - Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on iTunes, Stitcher and SoundCloud (click the highlighted links). Negative sentiment is being seen in the sto
Bristol-Myers Declines, FDA Delays Review of Opdivo for NSCLC http://www.zacks.com/stock/news/330339/bristol-myers-declines-fda-delays-review-of-opdivo-for-nsclc?cid=CS-ZC-FT-330339 Oct 23, 2018 - The FDA defers decision by three months regarding the sBLA of Bristol-Myers' (BMY) Opdivo in combination with Yervoy for the treatment of metastatic first-line NSCLC.
J&J makes $2.1 billion offer to buy out Japanese cosmetics firm Ci:z https://www.cnbc.com/2018/10/23/jj-makes-2point1-billion-offer-to-buy-out-japan-cosmetics-firm-ciz.html Oct 23, 2018 - U.S. health-care conglomerate Johnson & Johnson said on Tuesday it will buy all outstanding shares of Japanese skincare firm Ci:z Holdings that it does not already own for $2.05 billion in cash.
Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT http://www.zacks.com/stock/news/330069/biotech-stocks-earnings-lineup-for-oct-24-vrtx-alxn-srpt?cid=CS-ZC-FT-330069 Oct 23, 2018 - Three biotech stocks are scheduled to release their third-quarter results on Oct 24. Let's take a look at how these companies are poised ahead of their earnings release.
Buy Danaher For Total Return And 9% Yearly Growth https://seekingalpha.com/article/4213121-buy-danaher-total-return-9-percent-yearly-growth?source=feed_all_articles Oct 22, 2018 - Danaher's total return over-performed the DOW average for my 58-month test period by 19.14%, which is good for a company that has increased revenues, earnings, and dividends.Danaher's three-year forwa
Baby DivHut Dividend Income Portfolio Update Q3 2018 https://seekingalpha.com/article/4213072-baby-divhut-dividend-income-portfolio-update-q3-2018?source=feed_all_articles Oct 22, 2018 - With nine months of the year already behind us, it is time for me to highlight baby DivHut's quarterly dividend income/portfolio progress. Generally speaking, there is not much change in his portfolio
BIIB, ALKS Q3 Earnings Due on Oct 23: What's in Store? http://www.zacks.com/stock/news/329755/biib-alks-q3-earnings-due-on-oct-23-whats-in-store?cid=CS-ZC-FT-329755 Oct 22, 2018 - We take a look at some of the key factors of the two biotech stocks scheduled to release their third quarter results on Oct 23.
Stocks To Watch: Tech Earnings Bellwethers Set To Test Rally https://seekingalpha.com/article/4212924-stocks-watch-tech-earnings-bellwethers-set-test-rally?source=feed Oct 20, 2018 - Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday

Pages: 123456...422

Page 1>

Related Companies

Name Exchange Price Mkt Cap
PFE Pfizer, Inc. NYSE $43.01 $252.13B
NVS Novartis AG NYSE $85.13 $197.65B
MRK Merck & Company, Inc. NYSE $70.42 $187.28B
ABBV AbbVie Inc. NYSE $95.37 $144.42B
ABT Abbott Laboratories NYSE $67.67 $118.71B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Johnson & Johnson